| LPL | Lipoprotein Lipase |
| Aβ | Amyloid-Beta |
| AD | Alzheimer’s Disease |
| ApoC-II | ApoproteinC-II |
| ApoC-III | ApoproteinC-III |
| ChEIs | Cholinesterase inhibitors |
| DMTs | Disease-modifying therapeutics |
| TG | Triglycerides |
| VLDL | Very-low-density lipoprotein |
| CVD | Cardiovascular Disease |
| CNS | Central Nervous system |
| OPCs | Oligodendrocytes |
| GPIHBP | Glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 |
| TRL | Triglyceride-rich lipoproteins |
| LMF1 | Lipoprotein Maturation factor 1 |
| FFAs | Free Fatty Acids |
| LRP | LDL receptor-related protein/α2-macroglobulin receptor LRP2 |
| RAP | Receptor associated protein |
| HSPGs | Heparan sulfate proteoglycans |
| ANGPTL (3,4,8) | Angiopoietin-like protein (3,4,8) |
| HDL | High-density lipoproteins |
| DOCK | Dedicator of cytokinesis |
| APOE | Apoprotein E |
| CLU | Clusterin |
| ApoJ | Apoprotein J |
| TREM2 | Triggering receptor expressed on myeloid cells |
| PUFAs | Polyunsaturated fatty acids |
| SORLA | Sortilin |
| MS | Multiple Sclerosis |
| DAMS | Disease Associated Microglia |
| PAMS | Proliferative-region-associated-microglia |
| FCS | Familial chylomicronemia syndrome |
| LOAD | Late onset AD |
| CAD | Coronary Artery Disease |
| SAD | Sporadic AD |